The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Supratentorial gangliogliomas: Histopathologic grading and tumor recurrence in 184 patients with a median follow‐up of 8 years
Abstract
BACKGROUND: Supratentorial gangliogliomas (GGs) are rare tumors of the central nervous system and are commonly associated with chronic seizures. To date, only case reports and small series of patients with short‐term follow‐up have been available for the assessment of the potential of GGs to recur and progress. METHODS: Data from 184 patients who underwent resection of GGs between 1988 and 2001 were available from the University of Bonn Epilepsy Surgery Center (Bonn, Germany). Analysis of factors that influenced tumor recurrence and patient survival, such as preoperative history, age at operation, tumor location, histopathologic findings (including immunohistochemical findings), extent of tumor resection, and recurrence evaluated on postoperative magnetic resonance imaging (MRI), was performed. RESULTS: The median follow‐up period was 8 years (range, 1–14 years). One hundred seventy‐eight patients (97%) presented with long‐term seizures (≥ 2 years). The median age at surgery was 26 years (range, 2–65 years). Tumor location was temporal in 79% of patients and frontal in 12% of patients. Eleven tumors (6%) were classified as World Health Organization (WHO) Grade 2 lesions, and 2 tumors were classified as anaplastic WHO Grade 3 lesions. For 38 patients (21%), postoperative MRIs revealed residual tumors. Two years after surgery, 5 patients (3%) experienced tumor recurrence, which resulted in malignant progression in 3 patients (2%) and death in 2 patients (1%). Eighty‐four percent of patients with epilepsy had complete and sustained seizure relief. The calculated 7.5‐year recurrence‐free survival rate was 97%. Lower rates of recurrence were found in patients with tumors classified as WHO Grade 1 lesions (P < 0.0001), patients with temporal lesions (P < 0.0001), patients who underwent complete tumor resection (P = 0.0278), and patients with long‐standing epilepsy (P < 0.0001). CONCLUSIONS: Supratentorial GGs are benign tumors, and the surgical goal for patients with GG should be complete resection. Residual tumor masses, frontal tumor location, and WHO Grade 2 or 3 lesions are associated with a greater risk of recurrence or malignant progression. Patients with such characteristics should be considered for long‐term clinical follow‐up using MRI. Cancer 2004. © 2004 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Spiess, P. E., Lee, A. K., Leibovici, D., Wang, X., Do, K., & Pisters, L. L. (2006) · Cancer · doi:10.1002/cncr.21979 · Cited by 1,930
Pathology and genetics of tumours of the nervous system.
Kleihues, P., & Cavennee, W. (2000) · International Agency for Research on Cancer eBooks · Cited by 1,432
Luyken, C., Blümcke, I., Fimmers, R., Urbach, H., Elger, C. E., Wiestler, O. D., & Schramm, J. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.56102.x · Cited by 466
Self-citationGangliogliomas: An Intriguing Tumor Entity Associated With Focal Epilepsies
Blümcke, I., & Wiestler, O. D. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.7.575 · Cited by 378
Self-citationGanglioglioma: a detailed histopathological and immunohistochemical analysis of 61 cases
Wolf, H. K., M�ller, M. B., Sp�nle, M., Zenther, J., Schramm, J., & Wiestler, O. D. (1994) · Acta Neuropathologica · doi:10.1007/bf00294510 · Cited by 219
Self-citationBlümcke, I., Giencke, K., Wardelmann, E., Beyenburg, S., Kral, T., Sarioglu, N., Pietsch, T., Wolf, H. K., Schramm, J., Elger, C. E., et al. (1999) · Acta Neuropathologica · doi:10.1007/s004010051017 · Cited by 180
Self-citationSchramm, J., Kral, T., Grünwald, T., & Blümcke, I. (2001) · Journal of neurosurgery · doi:10.3171/jns.2001.94.1.0033 · Cited by 145
Self-citationSiegel, A. M., Wieser, H. G., Wichmann, W., & Yasargil, G. M. (1990) · Epilepsy Research · doi:10.1016/0920-1211(90)90009-k · Cited by 133
Blümcke, I., Becker, A. J., Normann, S., Hans, V., Riederer, B. M., Krajewski, S., Wiestler, O. D., & Reifenberger, G. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.10.984 · Cited by 95
Self-citationMutational analysis of TSC1 and TSC2 genes in gangliogliomas
Becker, A. J., Löbach, M., Klein, H., Normann, S., Nöthen, M. M., von Deimling, A., Mizuguchi, M., Elger, C. E., Schramm, J., Wiestler, O. D., et al. (2001) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2001.00302.x · Cited by 78
Self-citationA clinicopathologic and immunomorphologic study of 13 cases of ganglioglioma
Diepholder, H. M., Schwechheimer, K., Mohadjer, M., Knoth, R., & Volk, B. (1991) · Cancer · Cited by 71
Becker, A. J., Klein, H., Baden, T., Aigner, L., Normann, S., Elger, C. E., Schramm, J., Wiestler, O. D., & Blümcke, I. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0570-4 · Cited by 29
Self-citation
Cited by
Histologic classification of gliomas
(2016) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-802997-8.00005-0 · Cited by 297
Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments
Ruda, R., Bello, L., Duffau, H., & Soffietti, R. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos199 · Cited by 280
Long‐Term Epilepsy‐Associated Tumors
Thom, M., Blümcke, I., & Aronica, E. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00582.x · Cited by 231
Self-citationBlümcke, I., Vinters, H. V., Armstrong, D., Aronica, E., Thom, M., & Spreafico, R. (2009) · Epileptic Disorders · doi:10.1684/epd.2009.0261 · Cited by 145
Self-citationPathogenetic mechanisms of focal cortical dysplasia
Marin‐Valencia, I., Guerrini, R., & Gleeson, J. G. (2014) · Epilepsia · doi:10.1111/epi.12650 · Cited by 100
Metadata
- Authors
- Luyken, C., Blümcke, I., Fimmers, R., Urbach, H., Wiestler, O. D., & Schramm, J.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2004-05-28
- Volume
- 101
- Issue
- 1
- Pages
- 146-155
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1974104659
- Cited by
- 350
- References
- 13
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.